英国《卡斯评论》就跨性别青少年的医疗保健展开辩论，质疑青春期阻滞剂和激素的使用。 UK's Cass Review debates health care for transgender youth, questioning puberty blocker and hormone use.
由英国政府委托、希拉里·卡斯博士进行的“卡斯调查”引发了关于跨性别青年医疗保健的争论。 The UK's Cass Review, commissioned by the government and conducted by Dr. Hilary Cass, has sparked debate on health care for transgender youth. 虽然一些人赞扬该评论证明不应该给患有性别焦虑症的年轻人服用青春期阻滞剂和激素，但批评者认为，它忽视了证明心理健康结果改善的研究。 While some celebrate the review as proof that puberty blockers and hormones should not be given to young people with gender dysphoria, critics argue that it overlooks studies demonstrating improved mental health outcomes. 该报告呼吁对证据基础进行彻底审查，并对这些已在英国和其他地方对未成年人实施的治疗的安全性和有效性表示担忧。 The report calls for a thorough review of the evidence base and raises concerns about the safety and effectiveness of these treatments, which have been administered to minors in the UK and elsewhere.